The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities

TH Tran, SP Hunger - Seminars in cancer biology, 2022 - Elsevier
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and constitutes
approximately 25% of cancer diagnoses among children under the age of 15 (Howlader et …

Advancing diagnostics and therapy to reach universal cure in childhood ALL

R Pieters, CG Mullighan, SP Hunger - Journal of Clinical Oncology, 2023 - ascopubs.org
Systemic combination chemotherapy and intrathecal chemotherapy markedly increased the
survival rate of children with ALL. In the past two decades, the use of minimal (measurable) …

Genomic landscape of Down syndrome–associated acute lymphoblastic leukemia

Z Li, TC Chang, JJ Junco, M Devidas… - Blood, The Journal …, 2023 - ashpublications.org
Trisomy 21, the genetic cause of Down syndrome (DS), is the most common congenital
chromosomal anomaly. It is associated with a 20-fold increased risk of acute lymphoblastic …

[HTML][HTML] Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017

M Yi, L Zhou, A Li, S Luo, K Wu - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Acute lymphoblastic leukemia (ALL) is a common malignant hematologic disease that is
characterized by large numbers of dedifferentiated lymphoid cells. Statistical data of ALL's …

The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis

IS Muskens, S Li, T Jackson, N Elliot… - Nature …, 2021 - nature.com
Down syndrome is associated with genome-wide perturbation of gene expression, which
may be mediated by epigenetic changes. We perform an epigenome-wide association study …

Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome

AP Laurent, RS Kotecha, S Malinge - Leukemia, 2020 - nature.com
Structural and numerical alterations of chromosome 21 are extremely common in
hematological malignancies. While the functional impact of chimeric transcripts from fused …

Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia

M Bloom, JL Maciaszek, ME Clark, CH Pui… - Expert review of …, 2020 - Taylor & Francis
Introduction: Historically, the majority of childhood cancers, including acute lymphoblastic
leukemia (ALL), were not thought to have a hereditary basis. However, recent germline …

Cancer progress and priorities: childhood cancer

PJ Lupo, LG Spector - Cancer Epidemiology, Biomarkers & Prevention, 2020 - AACR
Background It is estimated that 300,000 children 0–19 years of age are diagnosed with
cancer worldwide each year (1). In high-income countries, cancer is the leading cause of …

Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood Cancer and …

PJ Lupo, TM Chambers, BA Mueller… - … journal of cancer, 2024 - Wiley Online Library
Although recent studies have demonstrated associations between nonchromosomal birth
defects and several pediatric cancers, less is known about their role on childhood leukemia …

Core-shell cisplatin/SiO2 nanocapsules combined with PTC-209 overcome chemotherapy–Acquired and intrinsic resistance in hepatocellular carcinoma

W Li, TOSB Solenne, H Wang, B Li, Y Liu, F Wang… - Acta Biomaterialia, 2023 - Elsevier
The primary cause of cisplatin resistance in liver cancer is reduced intracellular drug
accumulation and altered DNA repair/apoptosis signaling. Existing strategies to reverse …